Shares of Regeneron Pharmaceuticals Inc. REGN rallied 1.39% to $625.60 Wednesday, on what proved to be an all-around great ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

With the FDA appearing to be undergoing major disruption under new leadership, BofA analyst Tim Anderson says one way to assess the risk from ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) shares reached a new 52-week low on Monday after JPMorgan Chase & Co. lowered their price target on the stock from $1,100.00 to ...

Sei Investments Co. trimmed its Regeneron Pharmaceuticals stake by 11.3% in Q4, selling 3,371 shares and ending with 26,432.

This was the stock's second consecutive day of losses.

Four Gatton Academy students presented their research at the Louisville Regional Science and Engineering Fair. This year ...

Loomis Sayles & Co. has gone all in on Regeneron Pharmaceuticals, boosting its stake by 393,997 shares in Q4. This leap now ...

Falmouth High's Ryan Werthmann took the gold at Saturday's event, beating out more than 200 entries from 27 schools.

JPMorgan lowered the firm’s price target on Regeneron (REGN) to $1,000 from $1,100 and keeps an Overweight rating on the shares. The firm ...

The equity portion of the Abrdn Healthcare Investors Fund fell (gross of fees) but outperformed its custom benchmark over the ...

Adam Schleifer, a longtime financial fraud prosecutor, was dismissed from the U.S. Attorney's office in L.A. on Friday. He ...